Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06360419
Status:
RECRUITING
Last Update Posted:
2024-04-11
First Post:
2024-04-08
Brief Title:
Progressing TAAR-1 Dopamine and Norepinephrine in Depression Using Solriamfetol
Sponsor:
Axsome Therapeutics Inc
Organization:
Axsome Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-08
First Submit QC Date:
April 8 2024
Study First Post Date:
2024-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-08
Last Update Post Date:
2024-04-11
Last Update Post Date Type:
ACTUAL